Dual‐targeted nanomedicine delivering doxorubicin and nitric oxide for tumor immunomodulation and synergistic therapy

Documenti analoghi

• Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia
  di: Meihong Chai, et al.
  Pubblicazione: (2026)
• Ultrasmall Fe‐curcumin immunomodulators reinvigorate CAR‐T cells to potentiate solid tumor immunotherapy by mitigating cell exhaustion and senescence
  di: Jiazhi Duan, et al.
  Pubblicazione: (2026)
• Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
  di: Kaisheng You, et al.
  Pubblicazione: (2024)
• Multifunctional H 2 S‐activated metal‐organic framework systems for targeted colorectal cancer imaging and synergistic copper‐induced tumor regression
  di: Nannan Zheng, et al.
  Pubblicazione: (2025)
• Pt‐TiO 2 mesoporous nanosystem co‐delivering phlorezin enables synergistic sonodynamic‐chemoimmunotherapy for hepatocellular carcinoma via directly targeting DDX5 and metabolic reprogramming modulation
  di: Kairui Liu, et al.
  Pubblicazione: (2026)